Japan’s Medical Costs Down ¥16.3 Billion Due To Generic Promotion
This article was originally published in PharmAsia News
Executive Summary
Medical expenses in Japan decreased an estimated ¥16.3 billion between 2009 and 2012 thanks to the promotion of generic drug use, according to a Japan Health Insurance Association fiscal report announced July 9.